Canadian Patent No. 3043594, entitled “Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity,” provides Longeveron with patent rights in Canada through 2037.

ATLANTA, GA - December 15, 2025 ( NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced the ...

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...

The durability of vaccine-induced immunity is often limited by waning responses, antigenic drift, and anti-vector immunity, highlighting the need for innovative vaccination strategies. Heterologous ...

Investigators from Mass General Brigham have developed a way to promote antitumor immunity by hijacking cellular machinery within cancer cells. The study demonstrated that inducing cancer cells to ...

Cancer cells are among the most numerous cell types that comprise the tumor microenvironment, but with respect to immune therapy, they are often underutilized. Stimulator of interferon genes (STING) ...

Please provide your email address to receive an email when new articles are posted on . There were no serious bacterial infections or hospitalizations due to infection over 12 months among adults ...

Herd immunity occurs when enough people in a group are immune to a specific infection that it cannot spread easily from person to person. Vaccination programs have been successful in creating herd ...

Consumer Cellular is not like other phone companies. The mobile virtual network operator (MVNO) established its reputation by keeping things straightforward. John Marick and Greg Pryor founded the ...

The London Court of Appeal ruling against Saudi Arabia’s embassy in an employment immunity case signals a potential shift toward stricter limits on state immunity in workplace disputes, likely ...